AGL agilon health, inc.

NYSE · US · Healthcare · Medical Care Facilities · agilonhealth.com

84.28USD+0.17%Mkt Cap: 1.42B $P/E: —Today

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscr…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$26.85BUSDP/E 15.8

THC

Tenet Healthcare Corporation

$20.89BUSDP/E 10.0

FME

Fresenius Medical Care AG

$11.75BUSDP/E 12.1

FMS

Fresenius Medical Care AG

$12.05BUSDP/E 11.7

EHC

Encompass Health Corporation

Universal Health Services, Inc.

$10.38BUSDP/E 7.2

ENSG

The Ensign Group, Inc. - Common Stock

Concentra Group Holdings Parent, Inc.

$4.62BUSDP/E 23.4

LFST

LifeStance Health Group, Inc. - Common Stock

National HealthCare Corporation Common Stock

$3.57BUSDP/E 25.6

OPCH

Option Care Health, Inc. - Common Stock

$3.39BUSDP/E 17.2

AVAH

Aveanna Healthcare Holdings Inc. - Common Stock

$2.75BUSDP/E 10.0

GRDN

Guardian Pharmacy Services, Inc.

$2.67BUSDP/E 40.9

ACHC

Acadia Healthcare Company, Inc. - Common Stock

$2.61BUSD

BKD

Brookdale Senior Living Inc.

$2.51BUSD

Key Statistics

Company

Market Cap1.42B USD

Enterprise Value1.26B USD

Revenue (TTM)5.92B USD

Gross Profit-160.02M USD

Net Income (TTM)-391.35M USD

Revenue/Share356.25 USD

Last Price84.28 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees856

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)35.04

PEG—

EV/EBITDA-5.26

EV/Revenue0.21

P/S0.24

P/B6.21

EPS (TTM)-15.41

EPS (Forward)2.40

52W Range

7.48061% of range133.04

52W High133.04 USD

52W Low7.480 USD

Profitability

Gross Margin-2.70%

Oper. Margin1.30%

EBITDA Margin-4.05%

Profit Margin-6.60%

ROE-308.79%

ROA-30.78%

Growth

Revenue Growth7.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-105.76M USD

CapEx (TTM)43.11M USD

FCF Margin-2.46%

FCF Yield-10.29%

Net Debt-152.18M USD

Net Debt/EBITDA0.63

Balance Sheet

Debt/Equity0.29

Current Ratio1.08

Quick Ratio0.98

Book Value/Sh13.55 USD

Cash/Share11.05 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateMar 31, 2026

Analyst Consensus

Rating2.4 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)118.33 USD

Upside (mean)+40.4%

Target Range85.00 USD – 146.00 USD

85.00+40.4% to mean146.00

# Analysts12

Ownership

Shares Out.16.79M

Float10.93M

Insiders5.04%

Institutions96.56%

Short Interest

Short Ratio5.2d

Short % Float9.98%

Short % Out.6.26%

Shares Short1.05M

Short (prev mo.)978.83K

Technical

SMA 5090.71 (-7.1%)

SMA 20058.19 (+44.8%)

Beta3.04

S&P 52W Chg14.58%

Avg Vol (30d)214.20K

Avg Vol (10d)263.44K

Technical Indicators

RSI (14)45.9

MACD-3.4244

MACD Signal-3.3486

MACD Hist.-0.0757

BB Upper97.25 USD

BB Middle86.40 USD

BB Lower75.55 USD

BB Width25.11%

ATR (14)5.850 USD

Vol Ratio (20d)0.92x